VANCOUVER, BC -- (MARKET WIRE) -- February 20, 2007 -- Upstream Biosciences Inc. (OTCBB: UPBS) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, has announced that the Company has been accepted to join LifeSciences British Columbia, formerly known as BC Biotech. LifeSciences British Columbia supports and represents the life sciences community of British Columbia through leadership, advocacy and promotion of its world-class science and industry. British Columbia is home to three of Canada's largest and most successful biotechnology companies QLT, Angiotech, and Aspreva Pharmaceuticals. Today British Columbia is home to approximately 90 biotech companies.
